July 2007

Synthesis of large quantities of cGMP compounds nears completion.

March 2007

Initial clinical trials designed to further protect non-malignant tissues are completed in the Dominican Republic.

December 2006

Animal trials of new radiopharmaceuticals begin and additional collaborations with basic scientists developed to support these trials.

August 2006

JARI begins work on basic science of using alpha-particle emitting radionuclides for the therapy of malignancies which are more uniformly distributed in the body.

May 2006

JARI has proven its ability to selectively target cancer cells and tumors. These vectors delivered their payloads into the cancer cells, more specifically into the mitochondria of the cancer cells. Virtually every type of cancer tested so far has proven selective vector uptake - Colon Cancer, Pancreatic Cancer, Lung Cancer, Brain Cancer, Multiple Myeloma, Breast Cancer.

March 2006

Now as a commercial venture, with a philanthropic arm, JARI funded research in California, Colorado, Texas and Minnesota. Albeit sponsored research projects that JARI funded at the more sophisticated sites were well equipped for research, JARI has invested millions of dollars in equipment and construction internationally.

December 2005

In December of 2005, JARI, Mayo, the University of Minnesota and Giuliani Partners entered into an agreement where JARI Research Corporation was formed. Although it took from September of 2001 to December of 2005, JARI never stopped its philanthropic support of research, hiring of management and scientific personnel, or its commitment to this mission.

2005

In 2005, Mayo Clinic Foundation suggested that JARI start a Biotech company in partnership with Mayo and the University of Minnesota.

2003 - 2005

From 2003 to 2005, JARI sought to purchase a commercial Biotech company at the bequest of the researchers working with JARI. All of the research Scientists and Doctors believed it necessary to combine the private sector with academia to facilitate meaningful progress; however, the motives of the several Biotech companies that JARI considered were not in concert with JARI’s philosophy of this being a human race.

2001 - 2005

From 2001 to 2005, JARI philanthropically supported promising research projects domestically and internationally, actively becoming involved as adjuncts to the research projects.

September 2001

In September of 2001 JARI hired its first MD/PHD and began investigating cancer research projects worldwide.